Smoking is associated with reduced leptin and neuropeptide y levels and higher pain experience in patients with fibromyalgia

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Bokarewa, Maria I ^a   Erlandsson, Malin C ^a   Bjersing, Jan ^a   Dehlin, Mats ^a   Mannerkorpi, Kaisa ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; LEPTIN; NEUROPEPTIDE Y; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; SOMATOMEDIN C; SUBSTANCE P;

ACUTE CORONARY SYNDROME; ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BLOOD; BLOOD BRAIN BARRIER; BODY WEIGHT; CEREBROSPINAL FLUID; CONTROLLED STUDY; COPING BEHAVIOR; FEMALE; FIBROMYALGIA; GENETIC TRANSCRIPTION; HUMAN; HYPOTHALAMUS; INSULIN SENSITIVITY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN PARAMETERS; PERSONAL EXPERIENCE; PHYSIOLOGY; PRESSURE PAIN THRESHOLD; PROTEIN BLOOD LEVEL; SMOKING; SPINE INJURY; THALAMUS; VISUAL ANALOG SCALE; ADVERSE EFFECTS; CHEMICALLY INDUCED; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; FEMALE; FIBROMYALGIA; HUMANS; LEPTIN; MIDDLE AGED; NEUROPEPTIDE Y; PAIN; SMOKING;

EID: 84907246796     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/627041     Document Type: Article

References (65)

1. Gómez R., Conde J., Scotece M., Gómez-Reino J. J., Lago F., Gualillo O., What's new in our understanding of the role of adipokines in rheumatic diseases? Nature Reviews Rheumatology 2011 7 9 528 536 10.1038/nrrheum.2011.107 2-s2.0-80052409973
2. Matsuzawa Y., Funahashi T., Nakamura T., The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. Journal of Atherosclerosis and Thrombosis 2011 18 8 629 639 10.5551/jat.7922 2-s2.0-80052070656
3. Neumann E., Frommer K. W., Vasile M., Müller-Ladner U., Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis and Rheumatism 2011 63 5 1159 1169 10.1002/art.30291 2-s2.0-79955556433
4. Schulz C., Paulus K., Lehnert H., Adipocyte-brain: crosstalk. Results and Problems in Cell Differentiation 2010 52 189 201 10.1007/978-3-642-14426-4-16 2-s2.0-77957727077
5. Huang T., Wang Y., Chen S., The relation of serum leptin to body mass index and to serum cortisol in men with spinal cord injury. Archives of Physical Medicine and Rehabilitation 2000 81 12 1582 1586 10.1053/apmr.2000.9173 2-s2.0-0033663996
6. Langheim S., Dreas L., Veschini L., Maisano F., Foglieni C., Ferrarello S., Sinagra G., Zingone B., Alfieri O., Ferrero E., Maseri A., Ruotolo G., Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. American Journal of Physiology-Heart and Circulatory Physiology 2010 298 3 H746 H753 10.1152/ajpheart.00617.2009 2-s2.0-77749279595
7. Lübbeke A., Finckh A., Puskas G. J., Suva D., Lädermann A., Bas S., Fritschy D., Gabay C., Hoffmeyer P., Do synovial leptin levels correlate with pain in end stage arthritis? International Orthopaedics 2013 37 10 2071 2079 10.1007/s00264-013-1982-6 2-s2.0-84879722941
8. Maeda T., Kiguchi N., Kobayashi Y., Ikuta T., Ozaki M., Kishioka S., Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proceedings of the National Academy of Sciences of the United States of America 2009 106 31 13076 13081 10.1073/pnas.0903524106 2-s2.0-69149085109
9. Vázquez M. J., González C. R., Varela L., Lage R., Tovar S., Sangiao-Alvarellos S., Williams L. M., Vidal-Puig A., Nogueiras R., López M., Diéguez C., Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion. Endocrinology 2008 149 9 4534 4543 10.1210/en.2007-1708 2-s2.0-50449106902
10. Brown R. E., Wilkinson P. M. H., Imran S. A., Wilkinson M., Resistin differentially modulates neuropeptide gene expression and AMP-activated protein kinase activity in N-1 hypothalamic neurons. Brain Research 2009 1294 52 60 10.1016/j.brainres.2009.07.068 2-s2.0-70049097724
11. Lim G., Wang S., Zhang Y., Tian Y., Mao J., Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. The Journal of Clinical Investigation 2009 119 2 295 304 10.1172/JCI36785 2-s2.0-61749087425
12. Tian Y., Wang S., Ma Y., Lim G., Kim H., Mao J., Leptin enhances NMDA-induced spinal excitation in rats: a functional link between adipocytokine and neuropathic pain. Pain 2011 152 6 1263 1271 10.1016/j.pain.2011.01.054 2-s2.0-79956065269
13. Mitchell M. D., Mannino D. M., Steinke D. T., Kryscio R. J., Bush H. M., Crofford L. J., Association of smoking and chronic pain syndromes in Kentucky women. Journal of Pain 2011 12 8 892 899 10.1016/j.jpain.2011.02.350 2-s2.0-79961191874
14. Ekholm O., Grønbæk M., Peuckmann V., Sjøgren P., Alcohol and smoking behavior in chronic pain patients: the role of opioids. European Journal of Pain 2009 13 6 606 612 10.1016/j.ejpain.2008.07.006 2-s2.0-67349200665
15. Jakobsson U., Tobacco use in relation to chronic pain: results from a swedish population survey. Pain Medicine 2008 9 8 1091 1097 10.1111/j.1526-4637.2008.00473.x 2-s2.0-56849090230
16. Zvolensky M. J., Mcmillan K., Gonzalez A., Asmundson G. J. G., Chronic pain and cigarette smoking and nicotine dependence among a representative sample of adults. Nicotine and Tobacco Research 2009 11 12 1407 1414 10.1093/ntr/ntp153 2-s2.0-70849120494
17. Patterson A. L., Gritzner S., Resnick M. P., Dobscha S. K., Turk D. C., Morasco B. J., Smoking cigarettes as a coping strategy for chronic pain is associated with greater pain intensity and poorer pain-related function. The Journal of Pain 2012 13 3 285 292 10.1016/j.jpain.2011.11.008 2-s2.0-84857788632
18. Markkula R., Kalso E., Huunan-Seppala A., Koskenvuo M., Koskenvuo K., Leino-Arjas P., Kaprio J., The burden of symptoms predicts early retirement: a twin cohort study on fibromyalgia-associated symptoms. European Journal of Pain 2011 15 7 741 747 10.1016/j.ejpain.2011.01.004 2-s2.0-79960915554
19. Ditre J. W., Brandon T. H., Zale E. L., Meagher M. M., Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychological Bulletin 2011 137 6 1065 1093 10.1037/a0025544 2-s2.0-82855161003
20. Shi Y., Weingarten T. N., Mantilla C. B., Hooten W. M., Warner D. O., Smoking and pain: pathophysiology and clinical implications. Anesthesiology 2010 113 4 977 992 10.1097/ALN.0b013e3181ebdaf9 2-s2.0-77957890928
21. Brett K., Parker R., Wittenauer S., Hayashida K., Young T., Vincler M., Impact of chronic nicotine on sciatic nerve injury in the rat. Journal of Neuroimmunology 2007 186 1-2 37 44 10.1016/j.jneuroim.2007.02.005 2-s2.0-34248631658
22. Luo M., Chen Q., Ossipov M. H., Rankin D. R., Porreca F., Lai J., Spinal dynorphin and bradykinin receptors maintain inflammatory hyperalgesia. The Journal of Pain 2008 9 12 1096 1105 10.1016/j.jpain.2008.06.005 2-s2.0-56349144213
23. Clauw D. J., Fibromyalgia: an Overview. The American Journal of Medicine 2009 122 12 supplement S3 S13 10.1016/j.amjmed.2009.09.006 2-s2.0-70749145982
24. Wolfe F., Smythe H. A., Yunus M. B., Bennett R. M., Bombardier C., Goldenberg D. L., Tugwell P., Campbell S. M., Abeles M., Clark P., Fam A. G., Farber S. J., Fiechtner J. J., Franklin C. M., Gatter R. A., Hamaty D., Lessard J., Lichtbroun A. S., Masi A. T., The american college of rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis and Rheumatism 1990 33 2 160 172 10.1002/art.1780330203 2-s2.0-0025266660
25. Wolfe F., Ross K., Anderson J., Russell I. J., Hebert L., The prevalence and characteristics of fibromyalgia in the general population. Arthritis and Rheumatism 1995 38 1 19 28 10.1002/art.1780380104 2-s2.0-0028890678
26. Ablin J., Neumann L., Buskila D., Pathogenesis of fibromyalgia-a review. Joint Bone Spine 2008 75 3 273 279 10.1016/j.jbspin.2007.09.010 2-s2.0-43049137634
27. Hart R. P., Martelli M. F., Zasler N. D., Chronic pain and neuropsychological functioning. Neuropsychology Review 2000 10 3 131 149 10.1023/A:1009020914358 2-s2.0-0033851524
28. Burckhardt C. S., Clark S. R., Bennett R. M., Fibromyalgia and quality of life: a comparative analysis. Journal of Rheumatology 1993 20 3 475 479 2-s2.0-0027533874
29. Sicras-Mainar A., Rejas J., Navarro R., Blanca M., Morcillo A., Larios R., Velasco S., Villarroya C., Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Research & Therapy 2009 11 2 R54 10.1186/ar2673 2-s2.0-67650429049
30. Martínez-Lavín M., Overlap of fibromyalgia with other medical conditions. Current Pain and Headache Reports 2001 5 4 347 350 10.1007/s11916-001-0024-z 2-s2.0-0035430134
31. Smith H. S., Harris R., Clauw D., Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician 2011 14 2 E217 E245 2-s2.0-79952851361
32. Gracely R. H., Petzke F., Wolf J. M., Clauw D. J., Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis and Rheumatism 2002 46 5 1333 1343 10.1002/art.10225 2-s2.0-0036093275
33. Lee S. S., Kim S. H., Nah S. S., Lee J. H., Lee Y. A., Hong S. J., Kim H. S., Lee H. S., Kim H. A., Joung C. I., Choe J. Y., Smoking habits influence pain and functional and psychiatric features in fibromyalgia. Joint Bone Spine 2011 78 3 259 265 10.1016/j.jbspin.2010.07.018 2-s2.0-79955533845
34. Yunus M. B., Arslan S., Aldag J. C., Relationship between fibromyalgia features and smoking. Scandinavian Journal of Rheumatology 2002 31 5 301 305 10.1080/030097402760375214 2-s2.0-0036034129
35. Kosek E., Ekholm J., Nordemar R., A comparison of pressure pain thresholds in different tissues and body regions. Scandinavian Journal of Rehabilitation Medicine 1993 25 3 117 124 2-s2.0-0027488572
36. Nicklas B. J., Tomoyasu N., Muir J., Goldberq A. P., Effects of cigarette smoking and its cessation on body weight and plasma leptin levels. Metabolism: Clinical and Experimental 1999 48 6 804 808 10.1016/S0026-0495(99)90183-X 2-s2.0-0032997496
37. Kamohara S., Burcelin R., Halaas J. L., Friedman J. M., Charron M. J., Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997 389 6649 374 377 10.1038/38717 2-s2.0-0030847432
38. Fernández-Martos C. M., González P., Rodriguez F. J., Acute leptin treatment enhances functional recovery after spinal cord injury. PLoS ONE 2012 7 4 e35594 10.1371/journal.pone.0035594 2-s2.0-84859987404
39. Wolk R., Berger P., Lennon R. J., Brilakis E. S., Somers V. K., Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 2003 108 18 2206 2211 10.1161/01.CIR.0000095270.85646.E8 2-s2.0-0242361644
40. Karvonen-Gutierrez C. A., Harlow S. D., Jacobson J., Mancuso P., Jiang Y., The relationship between longitudinal serum leptin measures and measures of magnetic resonance imaging-assessed knee joint damage in a population of mid-life women. Annals of the Rheumatic Diseases 2014 73 5 883 889 10.1136/annrheumdis-2012-202685 2-s2.0-84875964902
41. Perruccio A. V., Mahomed N. N., Chandran V., Gandhi R., Plasma adipokine levels and their association with overall burden of painful joints among individuals with hip and knee osteoarthritis. The Journal of Rheumatology 2014 41 2 334 337 10.3899/jrheum.130709
42. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I., Visfatin: a protein secreted by visceral fat that Mimics the effects of insulin. Science 2005 307 5708 426 430 10.1126/science.1097243 2-s2.0-19944433652
43. Muse E. D., Obici S., Bhanot S., Monia B. P., McKay R. A., Rajala M. W., Scherer P. E., Rossetti L., Role of resistin in diet-induced hepatic insulin resistance. The Journal of Clinical Investigation 2004 114 2 232 239 10.1172/JCI200421270 2-s2.0-4043082182
44. Park S., Sang M. H., So R. S., Hye K. J., Long-term effects of central leptin and resistin on body weight, insulin resistance, and β -cell function and mass by the modulation of hypothalamic leptin and insulin signaling. Endocrinology 2008 149 2 445 454 10.1210/en.2007-0754 2-s2.0-38549176324
45. Elmquist J. K., Coppari R., Balthasar N., Ichinose M., Lowell B. B., Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. Journal of Comparative Neurology 2005 493 1 63 71 10.1002/cne.20786 2-s2.0-27744436291
46. Schwartz M. W., Seeley R. J., Campfield L. A., Burn P., Baskin D. G., Identification of targets of leptin action in rat hypothalamus. The Journal of Clinical Investigation 1996 98 5 1101 1106 10.1172/JCI118891 2-s2.0-0029739970
47. Decressac M., Barker R. A., Neuropeptide Y and its role in CNS disease and repair. Experimental Neurology 2012 238 2 265 272 10.1016/j.expneurol.2012.09.004 2-s2.0-84867003392
48. Girdler S. S., Maixner W., Naftel H. A., Stewart P. W., Moretz R. L., Light K. C., Cigarette smoking, stress-induced analgesia and pain perception in men and women. Pain 2005 114 3 372 385 10.1016/j.pain.2004.12.035 2-s2.0-15344348696
49. Huang H., Xu Y., van den Pol A. N., Nicotine excites hypothalamic arcuate anorexigenic proopiomelanocortin neurons and orexigenic neuropeptide Y neurons: similarities and differences. Journal of Neurophysiology 2011 106 3 1191 1202 10.1152/jn.00740.2010 2-s2.0-80052358867
50. Li M. D., Kane J. K., Effect of nicotine on the expression of leptin and forebrain leptin receptors in the rat. Brain Research 2003 991 1-2 222 231 10.1016/j.brainres.2003.08.024 2-s2.0-0142090719
51. Reseland J. E., Mundal H. H., Hollung K., Haugen F., Zahid N., Anderssen S. A., Drevon C. A., Cigarette smoking may reduce plasma leptin concentration via catecholamines. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005 73 1 43 49 10.1016/j.plefa.2005.04.006 2-s2.0-20444442060
52. Koc B., Bulucu F., Karadurmus N., Şahin M., Lower leptin levels in young non-obese male smokers than non-smokers. Upsala Journal of Medical Sciences 2009 114 3 165 169 10.1080/03009730902761631 2-s2.0-77957039128
53. Nagayasu S., Suzuki S., Yamashita A., Taniguchi A., Fukushima M., Nakai Y., Nin K., Watanabe N., Nagasaka S., Yabe D., Nishimura F., Smoking and adipose tissue inflammation suppress leptin expression in Japanese obese males: potential mechanism of resistance to weight loss among Japanese obese smokers. Tobacco Induced Diseases 2012 10 1 article 3 10.1186/1617-9625-10-3 2-s2.0-84863416836
54. Lee H., Joe K. H., Kim W., Park J., Lee D. H., Sung K. W., Kim D. J., Increased leptin and decreased ghrelin level after smoking cessation. Neuroscience Letters 2006 409 1 47 51 10.1016/j.neulet.2006.09.013 2-s2.0-33750988491
55. Hussain T., Al-Daghri N. M., Al-Attas O. S., Draz H. M., Abd Al-Rahman S. H., Yakout S. M., Plasma neuropeptide Y levels relate cigarette smoking and smoking cessation to body weight regulation. Regulatory Peptides 2012 176 1-3 22 27 10.1016/j.regpep.2012.02.005 2-s2.0-84860599034
56. Crofford L. J., Engleberg N. C., Demitrack M. A., Neurohormonal perturbations in fibromyalgia. Bailliere's Clinical Rheumatology 1996 10 2 365 378 10.1016/S0950-3579(96)80022-7 2-s2.0-0029890070
57. Anderberg U. M., Liu Z., Berglund L., Nyberg F., Elevated plasma levels of neuropeptide Y in female fibromyalgia patients. European Journal of Pain 1999 3 1 19 30 10.1016/S1090-3801(99)90185-4 2-s2.0-0032895251
58. Janssen J. A. M. J. L., Uitterlinden P., Hofland L. J., Lamberts S. W. J., Insulin-like growth factor I receptors on blood cells: their relationship to circulating total and "free" IGF-I, IGFBP-1, IGFBP-3 and insulin levels in healthy subjects. Growth Hormone and IGF Research 1998 8 1 47 54 2-s2.0-0032469331
59. Landin-Wilhelmsen K., Wilhelmsen L., Lappas G., Rosen T., Lindstedt G., Lundberg P. A., Bengtsson B. A., Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology 1994 41 3 351 357 10.1111/j.1365-2265.1994.tb02556.x 2-s2.0-0027935871
60. Faupel-Badger J. M., Berrigan D., Ballard-Barbash R., Potischman N., Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender. Annals of Epidemiology 2009 19 12 841 849 10.1016/j.annepidem.2009.08.005 2-s2.0-70450149009
61. Friedrich N., Jørgensen T., Juul A., Spielhagen C., Nauck M., Wallaschofski H., Linneberg A., Insulin-like growth factor i and anthropometric parameters in a Danish population. Experimental and Clinical Endocrinology and Diabetes 2012 120 3 171 174 10.1055/s-0031-1301289 2-s2.0-84857732474
62. Bennett R. M., Cook D. M., Clark S. R., Burckhardt C. S., Campbell S. M., Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. Journal of Rheumatology 1997 24 7 1384 1389 2-s2.0-0030839072
63. Cuatrecasas G., Riudavets C., Güell M. A., Nadal A., Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study. BMC Musculoskeletal Disorders 2007 8, article 119 10.1186/1471-2474-8-119 2-s2.0-38649128133
64. Bartell S. M., Rayalam S., Ambati S., Gaddam D. R., Hartzell D. L., Hamrick M., She J., Della-Fera M. A., Baile C. A., Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. Journal of Bone and Mineral Research 2011 26 8 1710 1720 10.1002/jbmr.406 2-s2.0-79960629585
65. Ross A. W., Johnson C. E., Bell L. M., Reilly L., Duncan J. S., Barrett P., Heideman P. D., Morgan P. J., Divergent regulation of hypothalamic neuropeptide Y and agouti-related protein by photoperiod in F344 rats with differential food intake and growth. Journal of Neuroendocrinology 2009 21 7 610 619 10.1111/j.1365-2826.2009.01878.x 2-s2.0-67149120740